SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?


To: arun gera who wrote (176813)8/20/2021 8:25:11 PM
From: TobagoJack  Respond to of 217786
 
Re <<Definitely alarming...long term effects are still unknown>>

Besides the prospectively dire problems with vaccines, am also waiting on conclusions from Israel which I believe would be indicative for everywhere else including HK that uses BioNTech mRNA liquid

I am hoping that 'they' release the second generation vaccines before end-Q4 2021 so that we can make better decisions before end-Q1 2022, in time for summer 2022. The current state does not and cannot work.

npr.org

Highly Vaccinated Israel Is Seeing A Dramatic Surge In New COVID Cases. Here's Why
Daniel Estrin



Medics in Jerusalem transfer a COVID-19 patient to Hadassah Hospital Ein Kerem. Many hospitals in Israel are at full capacity following a sharp increase in coronavirus infections.
Menahem Kahana/AFP via Getty Images
Israel was the first country on Earth to fully vaccinate a majority of its citizens against COVID-19. Now it has one of the world's highest daily infection rates — an average of nearly 7,500 confirmed cases a day, double what it was two weeks ago. Nearly one in every 150 people in Israel today has the virus.

What happened, and what can be learned about the vaccine's impact on a highly vaccinated country? Here are six lessons learned — and one looming question for the future of the pandemic.

1. Immunity from the vaccine dips over time.

Israel had fully vaccinated slightly over half its population by March 25. Infections waned, venues reopened to the vaccinated and the prime minister told Israelis to go out and have fun. By June, all restrictions, including indoor masking, were abolished.

But Israel paid a price for the early rollout. Health officials, and then Pfizer, said their data showed a dip in the vaccine's protection around six months after receiving the second shot.

2. The delta variant broke through the vaccine's waning protection.

It was a perfect storm: The vaccine's waning protection came around the same time the more infectious delta variant arrived in Israel this summer. Delta accounts for nearly all infections in Israel today.

Article continues after sponsor message

"The most influential event was so many people who went abroad in the summer — vacations — and brought the delta variant very, very quickly to Israel," said Siegal Sadetzki, a former public health director in Israel's Health Ministry.

3. If you get infected, being vaccinated helps.

The good news is that among Israel's serious infections on Thursday of this week, according to Health Ministry data, the rate of serious cases among unvaccinated people over age 60 (178.7 per 100,000) was nine times more than the rate among fully vaccinated people of the same age category, and the rate of serious cases among unvaccinated people in the under-60 crowd (3.2 per 100,000) was a little more than double the rate among vaccinated people in that age bracket.

The bad news, doctors say, is that half of Israel's seriously ill patients who are currently hospitalized were fully vaccinated at least five months ago. Most of them are over 60 years old and have comorbidities. The seriously ill patients who are unvaccinated are mostly young, healthy people whose condition deteriorated quickly.

Israel's daily average number of infections has nearly doubled in the past two weeks and has increased around tenfold since mid-July, approaching the numbers during Israel's peak in the winter. Deaths increased from five in June to at least 248 so far this month. Health officials say that currently 600 seriously ill patients are hospitalized, and they warn they cannot handle more than 1,000 serious infections at the same time.

4. Israel's high vaccination rate isn't high enough.

The country jumped out ahead of all other countries on vaccines, and 78% of eligible Israelis over 12 years old are vaccinated.

But Israel has a young population, with many under the eligible age for vaccination, and about 1.1 million eligible Israelis, largely between the ages of 12 and 20, have declined to take even one dose of the vaccine.

That means only 58% of Israel's total citizenry is fully vaccinated. Experts say that's not nearly high enough.

"We have a very large fraction of our population who are paying the price for a small fraction of the population who did not go to get the vaccine," said Eran Segal of the Weizmann Institute of Science, who advises the Israeli government on COVID-19.

Unvaccinated people helped fuel the rapid spread of the virus while the country remained open for business in recent months with few serious restrictions.

"That will lead to mass infection, which is exactly what we are seeing now," said Segal.

5. Vaccinations are key, but they are not enough.

Israel is trying to slow the wave without resorting to a new lockdown, which Prime Minister Naftali Bennett says would take an economic toll and "destroy the future of the country." The country is placing caps on gatherings, increasing hospital staff and pleading for unvaccinated people to get immunized.

On Israel's doorstep, the vaccination rate is much lower in the Israeli-occupied West Bank and the Gaza Strip. Only around 8% of Palestinians have been fully vaccinated. Palestinians are wary of certain brands of vaccine in ample supply, like AstraZeneca's, while Pfizer-BioNTech's vaccine is in shorter supply for Palestinians. But the Palestinian population is not a source of transmission in Israel. Only vaccinated Palestinians are given permits to enter Israel and Israeli settlements.

As for the low rate of vaccination in the West Bank and the Gaza Strip, "we don't have a shortage of vaccine. It is the hesitancy," said Randa Abu Rabe, a local World Health Organization official working in the Palestinian territories.



An Israeli health worker administers a third dose of the Pfizer-BioNTech vaccine at a vaccination center in Jerusalem. Israel is the first country to launch a national booster campaign for the Pfizer vaccine.
Menahem Kahana/AFP via Getty Images
6. Booster shots offer more protection — if you are one of the world's lucky few to get them.

Israel is the first country to offer a third shot of the Pfizer vaccine in a nationwide booster campaign. Preliminary research in Israel suggests booster shots significantly increase protection against the coronavirus a week after a person receives the third dose.

Israeli national HMO Maccabi Healthcare Services, which conducted the preliminary study of 149,144 Israelis who received three Pfizer shots, said for Israelis above age 60, a Pfizer booster shot reduced the chances of infection by 86% and reduced the chances of severe infection by 92%.

The early data reflects studies by vaccine-makers Pfizer and Moderna and provides a glimpse at boosters' effects in a real-world setting.

After reviewing data on breakthrough infections in Israel, the U.S. announced a booster shot campaign beginning in late September for anyone eight months after their second shot. The U.K. has promised boosters soon, and Turkey is offering Pfizer shots to those immunized with the Sinovac vaccine to help citizens planning to travel, since some countries will not recognize the Chinese vaccine.

Israel has lowered the minimum age for boosters to 40. "The triple dose is the solution to curbing the current infection outbreak," Anat Ekka Zohar of Maccabi said in a statement.

Boosters are not being offered in the Palestinian territories yet, and the World Health Organization has called on countries to stop giving COVID-19 booster shots in order to help poorer countries get vaccinated.

"Israel very much respects the World Health Organization but acts according to local considerations and the interests of Israeli citizens. We help the world a lot," an Israeli health official told NPR, speaking on condition of anonymity because he was not authorized to speak publicly about the issue. "If the U.N. didn't secure enough vaccines for Chad, Mali, Myanmar and Guatemala, that doesn't mean that Israel shouldn't seek to prevent a pandemic from happening here."

Experts warn if countries do not vaccinate their populations, more variants will develop, threatening even vaccinated nations.

Looming question: Will we need COVID-19 vaccines every several months? We don't know.

The Cinema City movie theater complex in Jerusalem teems with young children and parents, but steps from the box office is a makeshift vaccination station where dozens of mostly older residents wait their turn to get booster shots.

More than a million Israelis have received a Pfizer booster shot in the last several weeks. They are being watched around the world, as Israel is the first nation to give a third dose of Pfizer on a mass scale, just as it was ahead of the curve on the first round of shots.

"They make the test of us," said Etti Ben Yaakov, sitting in a vaccination booth with her brother as he got a booster shot. "But in the first [round], it was the same. So I don't feel it's something wrong. I think it's good."

She predicts the coronavirus, like the flu, will mean shots every year. "We will have to live with the corona," she said.

Ido Hadari, of HMO Maccabi, which led the preliminary booster shot study, questioned whether regular shots will become the norm.

"I don't know of any disease where we are vaccinated every six months, and to be honest, I don't think the public will come to get vaccinated every six months," Hadari said. "But you cannot predict anything with this disease."



To: arun gera who wrote (176813)8/20/2021 8:25:26 PM
From: TobagoJack  Read Replies (1) | Respond to of 217786
 
Re <<Definitely alarming...long term effects are still unknown>>

maybe the DNA vaccines would be better than the mRNA vaccines. See below articles from Bloomberg and BBC. Seems, by BBC read, all very tentative, not effective-enough, and also w/ lots of unknowable unknowns.

bloomberg.com

India Approves First DNA-based Covid Shot, Boosting Vaccine Plan
Chris Kay
20 August 2021, 23:24 GMT+8
India granted emergency-use approval to its first DNA-based vaccine against Covid-19 as the world’s second-worst-hit nation seeks to bolster its immunization drive to ward off a possible third wave of infections.

A three-dose vaccine developed by Ahmedabad-based Cadila Healthcare Ltd., which had reported 67% efficacy against symptomatic Covid in clinical trials in July, was given the go ahead on Friday, the government said in a statement. This is the second indigenously-developed shot to receive approval.

The shot, which Cadila claims works against newer virus strains, including the highly-infectious Delta variant, adds to the country’s arsenal in fighting the virus. Covid has so far sickened more than 32.3 million in the South Asian nation and killed more than 433,049, especially during a devastating second wave a few months back. Speedier inoculations -- known to reduce hospitalization and deaths -- are key to averting future virus waves in the densely-populated country.

The shot is “the world’s first and India’s indigenously developed DNA-based vaccine for Covid-19 to be administered in humans including children and adults 12 years and above,” Cadila said in a statement. It also plans to seek approval for a two-dose regimen of the vaccine and make a 100-120 million doses annually.

Forecaster Who Saw India’s Covid Peak Sees New Wave Coming

India, which has fully vaccinated only 9% of its population, has now approved six vaccines. Two of them from AstraZeneca Plc and one from Hyderabad-based Bharat Biotech International Ltd. are already widely in use. Russia’s Sputnik V has been administered in small numbers, while shots from Johnson & Johnson and Moderna Inc. aren’t being used as the makers continue to negotiate for legal indemnity.

Unlike traditional vaccines, Cadila’s ZyCoV-D is plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body and not a weakened form of the pathogen. Tokyo-based AnGes Inc. and the U.S.’s Inovio Pharmaceuticals Inc. are among other companies working on DNA-based vaccines. No DNA vaccine has been widely used against any disease thus far, but they are more stable and easier to store than mRNA shots.

Home to the world’s biggest vaccine-producing industry, India till early this year was seen as a major supplier of Covid vaccines to poorer nations around the world. But those plans went awry amid India’s deadly second wave, vaccine supply shortfalls and consequent export ban from the Indian government.

— With assistance by Shruti Srivastava

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE

*
*
*
*
*

bbc.com

India approves world's first DNA Covid vaccine

The three-dose ZyCoV-D vaccine prevented symptomatic disease in 66% of those vaccinated, according to an interim study quoted by the vaccine maker Cadila Healthcare.

The firm plans to make up to 120 million doses of India's second home-grown vaccine every year.

Previous DNA vaccines have worked well in animals but not humans.

India has so far given more than 570 million doses of three previously approved vaccines - Covishield, Covaxin and Sputnik V.

About 13% of adults have been fully vaccinated and 47% have received at least one shot since the beginning of the drive in January.

What we know about India's new Covid vaccines How India's vaccine drive went horribly wrong

Cadila Healthcare said it had conducted the largest clinical trial for the vaccine in India so far, involving 28,000 volunteers in more than 50 centres.

This is also the first time, the firm claimed, a Covid-19 vaccine had been tested in young people in India - 1,000 people belonging to the 12-18 age group. The jab was found to be "safe and very well tolerated" in this age group.

The key third phase of clinical trials was conducted at the peak of the deadly second wave of the virus. The vaccine maker believes this reaffirmed the jab's "efficacy against the mutant strains", especially the highly infectious Delta variant.

IMAGE SOURCEZYDUS CADILLA
image caption
The firm plans to make up to 120 million doses of the vaccine every year
"I am quite excited about the vaccine because it offers a lot of good potential. If this jab works, the future of vaccination becomes logistically simpler," said Prof Shahid Jameel, a well-known virologist.

How does this vaccine work?

DNA and RNA are building blocks of life. They are molecules that carry that genetic information which are passed on from parents to children.

Like other vaccines, a DNA vaccine, once administered, teaches the body's immune system to fight the real virus.

ZyCoV-D uses plasmids or small rings of DNA, that contain genetic information, to deliver the jab between two layers of the skin.

The plasmids carry information to the cells to make the "spike protein", which the virus uses to latch on and enter human cells.
Most Covid-19 vaccines work by giving the body instructions to make a fragment of the spike protein so it can trigger a person's immune system to produce antibodies and teach itself to fight off the virus.

What makes this vaccine difference?

This is the world's first human DNA vaccine against Covid-19.

There are a number of DNA vaccines approved in the US, for example, for use in animals, including a vaccine for a disease in horses and a skin cancer vaccine for dogs.



However, more than 160 different DNA vaccines are being tested in human clinical trials in the US. Most are devoted to treating existing cancers, and a third of the vaccines were for treating HIV.

ZyCov-D is also India's first needle-free Covid-19 jab.

It is administered with a disposable needle-free injector, which uses a narrow stream of the fluid to penetrate the skin and deliver the jab to the proper tissue.

"To have a DNA vaccine which works against an infection is a big deal. If it gives good protection this is something India will be proud of," said Dr Gagandeep Kang, a virologist and the first Indian woman to be elected Fellow of the Royal Society of London.

What are the advantages of a DNA vaccine?

Scientists say DNA vaccines are relatively cheap, safe and stable.

They can also be stored at higher temperatures - 2 to 8C.

Cadila Healthcare claims that their vaccine had shown "good stability" at 25C for at least three months - this would help the vaccine to be transported and stored easily.

What are the drawbacks of a DNA vaccine?

DNA vaccines developed for infectious diseases in humans have failed in the past.

"The problem is they work well in animals. But they don't end up offering the same level of immune response protection in humans," said Dr Kang.

The challenge, according to Dr Kang, was how to push the plasmid DNA into the human cell so that it gives a durable immune response.

Dr Jeremy Kamil, a virologist at Louisiana State University Health Sciences Center in Shreveport, echoed a similar sentiment.

"Plasmid DNA vaccines have been tried in the past. But we know it's very difficult to get plasmid DNA into the nucleus of human cells, especially in adults," Dr Kamil told me.

mRNA vaccines - which use messenger RNA, a molecule, to make the proteins - like Pfizer or Moderna do not need to reach the nucleus of the cell to be effective and offer higher efficacy and are likely to produce longer lasting immunity.

The other potential drawback is that ZyCoV-D requires three doses, instead of two for the other two candidates being used in India. The vaccine maker says it is evaluating at a two-dose jab.

"I would be delighted that a vaccine company overcame the immense challenges to make it work. But it's imperative that the efficacy data be vetted independently," said Dr Kamil.

However, more than 160 different DNA vaccines are being tested in human clinical trials in the US. Most are devoted to treating existing cancers, and a third of the vaccines were for treating HIV.

ZyCov-D is also India's first needle-free Covid-19 jab.

It is administered with a disposable needle-free injector, which uses a narrow stream of the fluid to penetrate the skin and deliver the jab to the proper tissue.

"To have a DNA vaccine which works against an infection is a big deal. If it gives good protection this is something India will be proud of," said Dr Gagandeep Kang, a virologist and the first Indian woman to be elected Fellow of the Royal Society of London.

What are the advantages of a DNA vaccine?

Scientists say DNA vaccines are relatively cheap, safe and stable.

They can also be stored at higher temperatures - 2 to 8C.

Cadila Healthcare claims that their vaccine had shown "good stability" at 25C for at least three months - this would help the vaccine to be transported and stored easily.

What are the drawbacks of a DNA vaccine?

DNA vaccines developed for infectious diseases in humans have failed in the past.

"The problem is they work well in animals. But they don't end up offering the same level of immune response protection in humans," said Dr Kang.

The challenge, according to Dr Kang, was how to push the plasmid DNA into the human cell so that it gives a durable immune response.

Dr Jeremy Kamil, a virologist at Louisiana State University Health Sciences Center in Shreveport, echoed a similar sentiment.

"Plasmid DNA vaccines have been tried in the past. But we know it's very difficult to get plasmid DNA into the nucleus of human cells, especially in adults," Dr Kamil told me.

mRNA vaccines - which use messenger RNA, a molecule, to make the proteins - like Pfizer or Moderna do not need to reach the nucleus of the cell to be effective and offer higher efficacy and are likely to produce longer lasting immunity.

The other potential drawback is that ZyCoV-D requires three doses, instead of two for the other two candidates being used in India. The vaccine maker says it is evaluating at a two-dose jab.

"I would be delighted that a vaccine company overcame the immense challenges to make it work. But it's imperative that the efficacy data be vetted independently," said Dr Kamil.



To: arun gera who wrote (176813)8/23/2021 4:18:26 AM
From: TobagoJack  Respond to of 217786
 
am wondering if all UN domains and Taiwan should agree to shutdown / shut-in and fiscally support population w/ free entertainment and food, for a period of say 60-days, during which period the medical network and law-enforcement system do iterative testing for and quarantine of afflicted to treat them until all-good, perhaps we might be rid of covid except for very isolated cluster that can be put out very expeditiously

Re China / HK, Australia, and New Zealand approach of zero-case vs ROW approach of whatever, the Aussies might surrender or wise-up (depending on PoV) at any moment now, and NZ might or not hold on, unclear to me that China shall not be joined by S Korea, Japan, etc etc if they can, but unless joined by ROW, untenable stance

the issue might be resolved one or another way, depending on the evolution path of the Covid variants going forward.

It’s clear China can stamp out the virus. The question remains how long it can hold out against the rest of the world.

bloomberg.com

China Hits Zero Covid Cases With a Month of Draconian Curbs

23 August 2021, 11:00 GMT+8



It’s been just over a month, and China has once again squelched Covid-19, bringing its local cases down to zero.

It was more difficult this time, even though the leaders of the world’s most populous nation used the same playbook they followed to quell more than 30 previous flare-ups. The arrival of the more infectious delta variant has raised the stakes, as the pathogen refines its ability to escape curbs and flout vaccination. It’s unclear how long the victory will last.

The China model shows what it takes to get Covid under control, and raises questions about whether other nations would be willing - or able - to follow the same draconian steps.

Here’s what happened between July 20, when news emerged of a cluster of infections among airport cleaning staff in the eastern city of Nanjing, and August 23, when China returned to Covid Zero.

Repeated mass testing of entire cities China took testing to an unprecedented level during this go-round. Local authorities checked their populations repeatedly, a dozen times in one city alone, to ensure every last infection was caught. In all, more than 100 million tests were administered. In the city of Yangzhou, some people were infected while waiting in line to get swabbed.

Note: Not every round of testing covers full population in the city



Quarantines also played a larger role. The Chinese capital of Beijing at one point was sealed off from other places with even a single case. It also cut off trains and flights from hotspots around the country, even though the city ultimately posted fewer than 10 infections in the delta flareup.

Other regions introduced sweeping curbs, from barring entry for people from high-risk areas to asking them to cut short vacations. Most had to remain isolated at home - a rule that was strictly enforced - before returning to work and school. More than 200 neighborhoods were labeled high- or medium-risk, triggering sweeping curbs that disrupted lives and businesses.

A Peak and a PlungeFirst there was one asymptomatic infection at the airport in Nanjing. The next day, there were more than a dozen. By the end of that week in July, daily infections had climbed to nearly 50, suggesting exponential spread across more than 1,000 kilometers. In less than three weeks, daily cases ballooned to more than 100, scattered across half of the nation. Then it ended, almost as quickly as it began. The number of infections dropped to single digits the next week amid tightening curbs, then zero. More testing will show if it has been vanquished.



The blazing spread of the delta variant across the country became the biggest test of China’s Covid control model. Ultimately it penetrated nearly 50 cities across 17 provinces and reintroduced the virus to Wuhan, which had been Covid-free for over a year.

Delta’s ShadowChina's delta variant outbreak had spread to over half of mainland China

Sources: National Health Commission, Bloomberg News

Note: Data shown is between July 21, when Nanjing’s cluster was first reported in the national tally, and Aug. 22









Still, China eliminated the virus in about a month, roughly the same time it took to quell previous outbreaks including one at the start of 2021 that totalled some 2,000 cases. In comparison, cities in Australia have undergone repeated lockdowns, keeping more than half of the country’s 26 million people confined to their homes, without gaining control of the virus. In the U.S., which has never succeeded in containment, relying instead of vaccination, booster shots are slated to roll out next month to shore up protection against its delta resurgence.

China has thus far kept all its infected patients alive. In the viral hotspot of Jiangsu province, critical cases at one point rose to as many as 18, raising fear that the country could see its first Covid fatalities in more than six months. Yet many have since shown signs of disease moderation and recovery.

Economic SetbackThe containment-at-all-costs approach is weighing on the world’s second largest economy. Consumption and manufacturing slowed in July, with further weakness expected for August when infections peaked and measures to control them intensified. Investment banks from Goldman Sachs Group Inc. to Nomura Holdings Inc. cut their growth projections.

China Slows More Than ExpectedSource: National Bureau of Statistics, Bloomberg surveys

Note: Jan.-Feb. data is combined each year


Covid Zero vs Co-ExistenceMore infectious variants and their rampant spread are making the global eradication of Covid-19 less likely. That realization is driving decisions in countries from Australia to Singapore to learn to live with the virus after they previously sought to eliminate it.

Still, China has proven its ability to keep the pathogen at bay, and it has vowed to continue, regardless of the effort or expense. Health minister Ma Xiaowei told the state news agency Xinhua on August 16 that authorities planned even stricter measures intended to spot incursions of the virus from abroad more quickly.

The health minister also reiterated that Covid containment provides a more stable environment for economic development and investment.

With the delta variant swirling globally, making herd immunity an impossibility, China is finding itself isolated in its zero tolerance approach. The threats from outside will continue. Some new cases over the past few days were reported in places like Shanghai, rather than in the most recent outbreak’s hotspots.

It’s clear China can stamp out the virus. The question remains how long it can hold out against the rest of the world.

— With assistance by John Liu, Dong Lyu, Claire Che, Amanda Wang, and Jinshan Hong

(Updating the Delta Shadow map)

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE